InsidersTradesSigma
Follow the 대한약품 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 대한약품 has logged 8 reports. Market capitalisation: €155.5bn. The latest transaction was filed on 30 June 2026 (Purchase). Among the most active insiders: 이윤우. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
대한약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing and distribution of pharmaceutical products.